StockData
Outlook Therapeutics, Inc. logo

Outlook Therapeutics, Inc. (OTLK) KPIs and segments

OTLKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 4/30
$0.36−0.04 (-8.94%)

Close on Nov 17, 2026Market cap $87.79MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Outlook Therapeutics's business

Coming soon

This tab will track the numbers specific to Outlook Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?